EUR 115.88 For Business Accounts Only

Med Discovery SA - Company Review

Med Discovery SA - Company Review

Summary

Med Discovery SA (Med Discovery) is a biopharmaceutical company that develops therapeutic proteins for the treatment of uro-genital cancers. The company’s pipeline product includes MDKP67b, a recombinant protease inhibitor that targets human kallikrein 2 for the treatment of prostate, bladder and ovarian cancer diseases. It develops protein drugs based on the optimization of natural proteins mixed up in the regulation of biological pathways. Med Discovery’s proprietary technology platform allows it to target cancers or other diseases where there is a lack of specific treatment by producing protease inhibitors. The company partners with various urology, pathology and laboratory medicine centers. Med Discovery is headquartered in Epalinges, Switzerland.

This comprehensive company report of Med Discovery SA provides you with company's businesses and operations information.

The profile contains critical company information including,

- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.